Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
mechanisms understanding and optimize treatment for mental health using computational tools, with a particular focus on developing ecologically valid computational frameworks and models. Our research uses both
-
, and functions as Yale Health’s flagship Epic Physician Builder. The role provides physician-level informatics leadership for Epic optimization, clinical decision support, workflow improvement, AI
-
neurodevelopmental disorders. The successful candidate will develop and apply experimental and computational approaches to understand gene regulation and disease mechanisms in neural development and to evaluate
-
to refine mechanisms understanding and optimize treatment for mental health using computational tools, with a particular focus on developing ecologically valid computational frameworks and models. Our
-
limited to stem cell and developmental biology, neuroscience, biochemistry, molecular and cell biology, computational biology and biomedical engineering. Research Focus ● Stem cell and developmental
-
positions in positron emission tomography (PET) imaging. Successful candidates will be expected to teach both undergraduate and graduate courses in related areas, develop a research program in collaboration
-
renewable; total duration varies by program/funding) Appointment Dates: ASAP – 1 year from date of hire Location: New Haven, CT (work travel expected to AL) Supervisor: Principal Investigator (PI) / Faculty
-
or disease. We are enthusiastic about candidates bridging traditional conceptual or methodological boundaries, and candidates linking experimental data with computational models from a variety of organisms
-
Neuroscience Faculty Positions - Computational (2026-2027) Yale University: School of Medicine: Basic Science -YSM: Neuroscience Location New Haven, CT Open Date Aug 10, 2026 Deadline Nov 30, 2026
-
– overarching goal of the research program is to define optimal cancer prevention and intervention strategies and match the right therapies to the right patients and to advance precision cancer care with real